Prime Therapeutics study shows wide variation in hemophilia treatment costs ST. PAUL, Minn., Oct. 11, 2013 /PRNewswire/ -- Treatment costs for the congenital bleeding disorders, hemophilia and von Willebrand's Disease (vWD) can vary substantially, from as little as $1,139 per ...
Oct. 11, 2013 - PR Newswire via Yahoo! Finance
Ali Karimi in Genetic Engineering News (press release) The Iranian medical community is extremely pleased and gratified to be making preparations for the arrival of Haemate P into Iran ,said Professor Mehran Karimi , University of Shiraz. "Nearly 700 patients with Type III von Willebrand...